• 1,700 exhibitors from 61 countries represented
  • The two-month online showcase attracted 19,699 attendees and facilitated 46,300 unique connections
  • 2022 co-located event will feature a live, in-person event from 24-27 January at the Dubai World Trade Centre and online format

Dubai, United Arab Emirates: Arab Health and Medlab Middle East, the leading exhibitions for the healthcare and laboratory industries in the MENA region, generated AED767.7 million of new business deals during the live, in-person element of the show last month.

During the four-day showcase, inaugurated by H.H. Sheikh Ahmed bin Saeed Al Maktoum, Chairman of Dubai Civil Aviation Authority and Chairman and Chief Executive of Emirates Airline and Group, the exhibitions welcomed 22,800 visitors from 172 countries who connected with 1,700 exhibitors. A total of 61 countries were represented by exhibitors, which included 30 international pavilions.  

Wouter Molman, Executive Vice President for Informa Markets, said: “Arab Health and Medlab Middle East have been a resounding success this year and underscored the importance, and perhaps, more importantly, the demand, to host live and in-person events once again. Our overarching goal was to create a platform that was conducive to facilitating business deals by providing an opportunity to make connections, network and ultimately to support global healthcare recovery.”

Deals completed during the event included a collaboration between American Hospital Dubai and Etisalat Digital to enhance the patient experience by utilising multiple digital technologies. The Ministry of Health and Prevention, the EHSE, the DHA and DoH also signed a bulk purchase agreement for medicines and medical supplies.

Al Jalila Children’s Specialty Hospital (AJCSH) announced a high-profile agreement with Illumina Netherlands BV, the world’s leader in next-generation sequencing, to provide technical expertise, reagents and analysis tools and training to the group.

Elsewhere on the show floor, Gulf Medical University signed an MOU with GEOTAR-Med LLC, a leading company in Russia providing complex turnkey solutions for medical education, to develop, produce and advance exciting simulation equipment for education in healthcare professions.

At Medlab Middle East, a series of deals were completed, including G42 Healthcare who announced a partnership with Seegene, a global biotechnology company specialising in molecular diagnostics, to offer fully equipped mobile diagnostics and testing laboratories across the Mena region. Further announcements included Unilabs new diagnostic solutions deal with Roche Diagnostics.

Vincenzo Ventricelli, CEO, Philips Middle East, Turkey & Africa, said: “We’ve been very pleased with the positive feedback we’ve received during the show. Not only have customers been willing to come to the event, but they are also happy to engage, discuss, and make decisions in a face-to-face environment. This means business is being done faster and better.”

As part of the online element of the show, 19,699 visitors attended from countries including Chile, Congo, Mauritius, Zambia, Bolivia, Costa Rica & Dominican Republic, totaling over 31 countries who were only represented online thanks to the virtual aspect of the exhibitions. A survey of online participants revealed that 47% of online attendees had never attended either show in the past.

“These results underscore the importance of our online event by providing an opportunity for an even greater audience to participate. While the physical events remain a strong and impactful platform, which resulted in millions of dirhams worth of business generated at the in-person shows, the online element has so far facilitated over 46,300 unique connections from around the world," added Molman.   

The events, which took place under the theme of 'United by business, driving the industry forward’, was supported by the Ministry of Health and Prevention (MoHAP), Dubai Healthcare City Authority, Dubai Health Authority, and the Dubai Government.

As part of Informa Markets commitment to provide the highest hygiene levels at all events by ensuring attendees and staff safety, the event took place with protocols introduced via the company’s Informa AllSecure health and safety mandate. The enhanced measures include 35 guidelines covering all aspects of cleaning and hygiene, social distancing measures, and the use of PPE, screening, and a track and trace in conjunction with local authorities.

The 2022 edition of the show, which returns as a co-located event for the healthcare and laboratory industries, will take place from 24 – 27 January at the Dubai World Trade Centre.

“As an organiser, the learnings from hosting a live, in-person event concurrently with the online edition have been invaluable. The results have exceeded our expectations. As with our show theme this year, now is the time to drive the industry forward and prepare for 2022, where we look forward to replicating this year’s successes," concluded Molman.

For more information, please visit www.arabhealthonline.com or medlabme.com

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.